MCE 的所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。

Lometrexol hydrate

CAS No. : 1435784-14-7

MCE 站：Lometrexol hydrate

产品活性：Lometrexol hydrate (DDATHF hydrate) 是一种抗嘌呤类抗叶酸 (antifolate) 药，可抑制甘氨酰胺核糖核苷酸甲酰基转移酶 (GARFT) 的活性，但不会引起可检测水平的 DNA 链断裂。Lometrexol hydrate 可以进一步抑制嘌呤从头合成，导致异常的细胞增殖，凋亡 (apoptosis) 和细胞周期停滞。Lometrexol hydrate 具有抗癌活性。

研究领域：Cell Cycle/DNA Damage  |  Apoptosis

作用靶点：Antifolate  |  Apoptosis

In Vitro: Lometrexol hydrate (DDATHF hydrate) binds tightly to GART, resulting in a rapid and prolonged depletion of intracellular purine ribonucleotides.
Lometrexol hydrate (1-30 μM; 2-10 hours) induces rapid and complete growth inhibition in L1210 cells.
Lometrexol hydrate (1 μM; 2-24 hours) induces cell cycle arrest in murine leukemia L1210 cells.
Lometrexol hydrate induces abnormal proliferation and apoptosis exist in neural tube defects (NTDs).

In Vivo: Lometrexol hydrate (DDATHF hydrate; i.p.; 15-60 mg/kg; on gestation day 7.5) increases the rate of embryonic resorption and growth retardation in a dose-dependent manner.
Lometrexol hydrate (i.p.; 40 mg/kg) maximally inhibits GARFT activity after at 6 hours and thereafter gradually increases with time but remains significantly lower than control even at 96 hours. Levels of ATP, GTP, dATP and dGTP of NTDs embryonic brain tissue decreases significantly at 6 h, and more significantly over time.

相关产品：Apoptosis Compound Library  |  Anti-Aging Compound Library  |  Anti-Cancer Compound Library  |  Cell Cycle/DNA Damage Compound Library  |  Bioactive Compound Library Plus  |  MG-132  |  LY294002  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Paclitaxel  |  Y-27632 dihydrochloride  |  SP600125  |  Sorafenib  |  Angiotensin II human  |  Staurosporine  |  5-Fluorouracil  |  Trametinib  |  MK-2206 dihydrochloride  |  Bortezomib  |  Tamoxifen  |  Acetylcysteine  |  Pexidartinib  |  Gemcitabine  |  BAY 11-7082  |  Decitabine  |  2-Deoxy-D-glucose  |  Temozolomide  |  Verteporfin  |  Ruxolitinib  |  Etoposide  |  Docetaxel  |  Dasatinib  |  DAPT  |  Everolimus

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。